Adam Koppel - 06 Jun 2023 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: SLDB
Reported as of: 06 Jun 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Jun 2023, 17:01:01 UTC
Prior SEC filing: 15 Dec 2022
Next SEC filing: 09 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ Adam Koppel

Key filing fact

Adam Koppel filed Form 4 for Solid Biosciences Inc. (SLDB) on 08 Jun 2023.

Key facts

This page summarizes Adam Koppel's Form 4 filing for Solid Biosciences Inc. (SLDB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 08 Jun 2023, 17:01.

Change

Previous filing in this sequence was filed on 15 Dec 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SLDB transaction Derivative

Director Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +9,650
Change %
Price: $0.000000
Shares after: 9,650
Date: 06 Jun 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 9,650
Exercise price: $6.37
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option was granted on June 6, 2023 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.